Furthermore, METTL3 promotes the temozolomide (TMZ) resistance of glioma cells by increasing DNA repair genes O6-methylguanine-DNA methyltransferase (MGMT) and alkylpurine–DNA–N-glycosylase (ANPG) [82]. Here, MGMT is linked to glioma.